Lindbrook Capital »

Olema Pharmaceuticals shares owned by Lindbrook Capital

Quarter-by-quarter ownership of Olema Pharmaceuticals (OLMA) shares owned by Lindbrook Capital from 13F filings

Historical chart of Lindbrook Capital investment in Olema Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Olema Pharmaceuticals held by Lindbrook Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Olema Pharmaceuticals by Lindbrook Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.8k 158 11.32
2023-12-31 $2.2k 158 14.03
2023-09-30 $2.0k 158 12.35
2023-06-30 $1.4k 158 9.03

More positions owned by Lindbrook Capital

Vanguard Total Stk Mkt Etf (VTI)
Vanguard Total Intl Stock Idex Etf Etf (VXUS)
Golub Cap Bdc Cef (GBDC)
Apple Stock (AAPL)
Spdr S&p 500 Etf Trust Etf (SPY)
Ishares Russell 1000 Growth Etf Etf (IWF)
Nvidia Corporation Stock (NVDA)
Microsoft Stock (MSFT)
Rpar Risk Parity Etf Etf (RPAR)
Ishares Russell 1000 Value Etf Etf (IWD)
Amazon.com Stock (AMZN)
Powershares Qqq Tr Etf (QQQ)
Oaktree Specialty Lending Corp Cef (OCSL)
Vertex Pharmaceuticals In Stock (VRTX)
Broadcom Stock (AVGO)

View all positions for Lindbrook Capital

Top funds holding Olema Pharmaceuticals

BVF
Paradigm Biocapital Advisors
Logos Global Management
Vanguard Group
Cormorant Asset Management
Vivo Capital
Dimensional Fund Advisors
Henderson Group
First Light Asset Management
Victory Capital Management
Kingdon Capital Management
Perceptive Advisors
Citadel Advisors
Goldman Sachs Group
Marshall Wace

View all funds holding Olema Pharmaceuticals